Cytrellis Biosystems, Inc.

34 Commerce Way, Woburn, Massachusetts, United States

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

90.0%

Trial Status Distribution

Completed

50.0%

Enrolling By Invitation

20.0%

Recruiting

20.0%

Unknown

10.0%

Clinical Trials

Trials sponsored by this organization (10)

Micro-Coring® for the Treatment of Skin Laxity of the Knees

Not Applicable

Enrolling By Invitation

interventional

Feb 202612 participants

Safety and Efficacy of Ellacor® Micro-coring® Following Best Practices on Technique and Post-Procedural Care

Not Applicable

Enrolling By Invitation

interventional

Nov 202524 participants

Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

Recruiting

observational

Oct 202510 participants

Healing Study of Fractional Skin Resurfacing and Tissue Histopathology After Ellacor Treatment

Not Applicable

Completed

interventional

Apr 20243 participants

Open Label Study Exploring Tissue Histopathology After Ellacor® Procedure in an Abdominoplasty Model.

Not Applicable

Completed

interventional

Feb 20236 participants

Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles

Not Applicable

Recruiting

interventional

Nov 201835 participants

Study to Evaluate the Efficacy of a Micro Coring Device for the Treatment of Scars of the Cytrellis Micro-Coring Device for the Treatment of Scars

Not Applicable

Unknown

interventional

Sep 201830 participants

Pivotal Study to Evaluate the Safety and Efficacy of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles

Not Applicable

Completed

interventional

Mar 201830 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations